Hervás-Stubbs S - Search Results

1

Advances in immunotherapy for hepatocellular carcinoma.

Sangro B, Sarobe P, Hervás-Stubbs S, Melero I. Sangro B, et al. Nat Rev Gastroenterol Hepatol. 2021 Aug;18(8):525-543. doi: 10.1038/s41575-021-00438-0. Epub 2021 Apr 13. Nat Rev Gastroenterol Hepatol. 2021. PMID: 33850328 Free PMC article. Review.

2

Overcoming class II-linked non-responsiveness to hepatitis B vaccine.

Hervás-Stubbs S, Berasain C, Golvano JJ, Lasarte JJ, Prieto I, Sarobe P, Prieto J, Borrás-Cuesta F. Hervás-Stubbs S, et al. Vaccine. 1994 Aug;12(10):867-71. doi: 10.1016/0264-410x(94)90026-4. Vaccine. 1994. PMID: 7526566 Free article.

3

Simple strategy to induce antibodies of distinct specificity: application to the mapping of gp120 and inhibition of HIV-1 infectivity.

Prieto I, Hervás-Stubbs S, García-Granero M, Berasain C, Riezu-Boj JI, Lasarte JJ, Sarobe P, Prieto J, Borrás-Cuesta F. Prieto I, et al. Eur J Immunol. 1995 Apr;25(4):877-83. doi: 10.1002/eji.1830250403. Eur J Immunol. 1995. PMID: 7737288

4

Therapeutic vaccination of woodchucks against chronic woodchuck hepatitis virus infection.

Hervás-Stubbs S, Lasarte JJ, Sarobe P, Prieto J, Cullen J, Roggendorf M, Borrás-Cuesta F. Hervás-Stubbs S, et al. J Hepatol. 1997 Oct;27(4):726-37. doi: 10.1016/s0168-8278(97)80090-6. J Hepatol. 1997. PMID: 9365049 Free article.

5

T-helper cell response to woodchuck hepatitis virus antigens after therapeutic vaccination of chronically-infected animals treated with lamivudine.

Hervás-Stubbs S, Lasarte JJ, Sarobe P, Vivas I, Condreay L, Cullen JM, Prieto J, Borrás-Cuesta F. Hervás-Stubbs S, et al. J Hepatol. 2001 Jul;35(1):105-11. doi: 10.1016/s0168-8278(01)00063-0. J Hepatol. 2001. PMID: 11495027

6

Recombinant adenoviral vectors turn on the type I interferon system without inhibition of transgene expression and viral replication.

Huarte E, Larrea E, Hernández-Alcoceba R, Alfaro C, Murillo O, Arina A, Tirapu I, Azpilicueta A, Hervás-Stubbs S, Bortolanza S, Pérez-Gracia JL, Civeira MP, Prieto J, Riezu-Boj JI, Melero I. Huarte E, et al. Mol Ther. 2006 Jul;14(1):129-38. doi: 10.1016/j.ymthe.2006.02.015. Epub 2006 Apr 19. Mol Ther. 2006. PMID: 16627004 Free article.

7

Immunogenic cell death and cross-priming are reaching the clinical immunotherapy arena.

Melero I, Arina A, Murillo O, Dubrot J, Alfaro C, Pérez-Gracia JL, Bendandi M, Hervás-Stubbs S. Melero I, et al. Clin Cancer Res. 2006 Apr 15;12(8):2385-9. doi: 10.1158/1078-0432.CCR-06-0314. Clin Cancer Res. 2006. PMID: 16638842 Free article. No abstract available.

8

The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo.

Lasarte JJ, Casares N, Gorraiz M, Hervás-Stubbs S, Arribillaga L, Mansilla C, Durantez M, Llopiz D, Sarobe P, Borrás-Cuesta F, Prieto J, Leclerc C. Lasarte JJ, et al. J Immunol. 2007 Jan 15;178(2):748-56. doi: 10.4049/jimmunol.178.2.748. J Immunol. 2007. PMID: 17202335

9

Immunostimulatory monoclonal antibodies for cancer therapy.

Melero I, Hervas-Stubbs S, Glennie M, Pardoll DM, Chen L. Melero I, et al. Nat Rev Cancer. 2007 Feb;7(2):95-106. doi: 10.1038/nrc2051. Nat Rev Cancer. 2007. PMID: 17251916 Review.

10

Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer.

Arina A, Murillo O, Dubrot J, Azpilikueta A, Alfaro C, Pérez-Gracia JL, Bendandi M, Palencia B, Hervás-Stubbs S, Melero I. Arina A, et al. Expert Opin Biol Ther. 2007 May;7(5):599-615. doi: 10.1517/14712598.7.5.599. Expert Opin Biol Ther. 2007. PMID: 17477799 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

105 results

Search Page